PHARMAMAR SA has a total of 14 patent applications. Its first patent ever was published in 1993. It filed its patents most often in United States, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are FARMA MAR S A, SIGNALRX PHARMACEUTICALS INC and LEGOCHEM BIOSCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | China | 1 | |
#3 | EPO (European Patent Office) | 1 | |
#4 | Poland | 1 | |
#5 | Taiwan | 1 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Peptides | |
#5 | Fermentation | |
#6 | Microorganisms | |
#7 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Lopez Lazaro Luis | 4 |
#2 | Gravalos Dolores G | 4 |
#3 | Ruiz Casado Ana | 4 |
#4 | Rowinsky Eric | 3 |
#5 | Jimeno Jose | 3 |
#6 | Hidalgo Manuel | 3 |
#7 | Rinehart Kenneth L | 2 |
#8 | Hamann Mark T | 2 |
#9 | Scheuer Paul J | 2 |
#10 | De La Calle Fernando | 1 |
Publication | Filing date | Title |
---|---|---|
US5756734A | Crambescidins: new antiviral and cytotoxic compounds from the sponge crambe crambe | |
US5514705A | Epidioxymanadic acids A and B | |
US5514708A | Cytotoxic metabolites from Myriapora truncata | |
US6274551B1 | Cytotoxic and antiviral compound | |
US5556777A | Immunosuppressive pharmaceutical compositions new biological activity from a marine agrobacterium sp. |